People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of developing ALS, a new study finds. Photo by Adobe Stock/HealthDay News People ...

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...

People with rare genetic variants that are linked to Parkinson’s disease and other neurodegenerative disorders have a higher risk for developing amyotrophic lateral sclerosis (ALS), also called Lou ...

Recently, a scientific breakthrough answered a big question for a man named Jeff and his siblings. Their mother and her three ...

DE PERE, Wis. (WFRV) – A local family that has a rare form of Amyotrophic Lateral Sclerosis (ALS), or sometimes referred to as Lou Gehrig’s disease, is continuing to fight and research through their ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness and eventually death. While ...

Amyotrophic lateral sclerosis (ALS) cannot spread through contact or proximity, so it is not contagious. Most cases of ALS occur without a known trigger or reason, although some cases occur due to ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurological condition that eventually results in the loss of the ability to walk, talk, and swallow. In most cases, the cause of ALS is unknown.